| Pharmaceutical active ingredients: |
| IsoniazidPyrazinamideRifampin |
| Available forms, composition and doses of Pyrifin: |
| N / A |
| Pyrifin medical category: |
| Human:Antituberculosis agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| J04AM05 - Rifampicin, Pyrazinamide and Isoniazid |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-Aventis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Montorip | Isoniazid; Pyrazinamide; Rifampin | Shreya Life Sciences |
| Montorip Forte | Isoniazid; Pyrazinamide; Rifampin | Shreya Life Sciences |
| Montorip Kid | Isoniazid; Pyrazinamide; Rifampin | Shreya Life Sciences |
| Mycocox-Z | Isoniazid; Pyrazinamide; Rifampin | Cadila |
| Mycurit-Z | Isoniazid; Pyrazinamide; Rifampin | Cadila |
| R-Cinex Z | Isoniazid; Pyrazinamide; Rifampin | Lupin Pharmaceuticals |
| Rcinex-Z | Isoniazid; Pyrazinamide; Rifampin | Lupin Pharmaceuticals |
| RF-3 | Isoniazid; Pyrazinamide; Rifampin | Sunij Pharma |
| RF-3 Forte | Isoniazid; Pyrazinamide; Rifampin | Sunij Pharma |
| RHZ | Isoniazid; Pyrazinamide; Rifampin | Overseas Health Care |